Haoyue Hu

718 total citations
31 papers, 524 citations indexed

About

Haoyue Hu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haoyue Hu has authored 31 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haoyue Hu's work include Cancer Immunotherapy and Biomarkers (4 papers), Ubiquitin and proteasome pathways (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Haoyue Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Ubiquitin and proteasome pathways (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Haoyue Hu collaborates with scholars based in China, Taiwan and Canada. Haoyue Hu's co-authors include Li Wang, Feng Luo, Yuxiang Han, Chang Gu, Ning Wu, Hong-Yan Gu, Jun He, Yanyang Liu, Xue Fan and Feng Luo and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and International Journal of Obesity.

In The Last Decade

Haoyue Hu

28 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haoyue Hu China 11 251 163 140 101 96 31 524
Fei Lian United States 16 336 1.3× 192 1.2× 163 1.2× 58 0.6× 214 2.2× 33 672
Zhuoqing Xu China 13 340 1.4× 266 1.6× 198 1.4× 132 1.3× 102 1.1× 25 629
He-Li Gao China 9 207 0.8× 312 1.9× 171 1.2× 71 0.7× 97 1.0× 10 526
Yongqian Jia China 13 343 1.4× 137 0.8× 149 1.1× 45 0.4× 88 0.9× 43 587
Omar Elaskalani Australia 8 240 1.0× 246 1.5× 99 0.7× 198 2.0× 65 0.7× 11 568
Shrey Modi United States 10 243 1.0× 248 1.5× 122 0.9× 133 1.3× 41 0.4× 21 574
Stephanie Annett Ireland 12 252 1.0× 169 1.0× 98 0.7× 58 0.6× 48 0.5× 16 495
Andrea Pretta Italy 12 182 0.7× 272 1.7× 139 1.0× 59 0.6× 102 1.1× 47 478
Tomoyuki Uchihara Japan 13 263 1.0× 307 1.9× 174 1.2× 126 1.2× 187 1.9× 30 654

Countries citing papers authored by Haoyue Hu

Since Specialization
Citations

This map shows the geographic impact of Haoyue Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyue Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyue Hu more than expected).

Fields of papers citing papers by Haoyue Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyue Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyue Hu. The network helps show where Haoyue Hu may publish in the future.

Co-authorship network of co-authors of Haoyue Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyue Hu. A scholar is included among the top collaborators of Haoyue Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyue Hu. Haoyue Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Haoyue. (2025). Complete response to anti-PD1 therapy and chemotherapy in a patient with ALK-rearranged non-small cell lung cancer. International Journal of Clinical and Experimental Pathology. 18(1). 37–41.
2.
Wang, Qian, Huiyi Chen, Huiling Deng, et al.. (2025). Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes. Diabetes & Metabolism. 51(3). 101628–101628. 4 indexed citations
3.
4.
Peng, You, Jun Chen, Chi Chiu Wang, et al.. (2025). PGK1 Regulates Oxidative Stress in Gestational Diabetes Mellitus through the Estradiol-Keap1-Nrf2 Pathway. International Journal of Biological Sciences. 21(12). 5496–5513. 1 indexed citations
5.
Wang, Gaigai, et al.. (2024). LINC01320 facilitates cell proliferation and migration of ovarian cancer via regulating PURB/DDB2/NEDD4L/TGF-β axis. Scientific Reports. 14(1). 26233–26233. 1 indexed citations
6.
Hu, Haoyue, Meng Xie, Peng Guo, et al.. (2023). Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer. Frontiers in Pharmacology. 14. 1167959–1167959. 2 indexed citations
7.
8.
Li, Linjuan, Xiaofen Li, Qiang Wu, et al.. (2022). Case report: Long-term partial response of apatinib plus paclitaxel as second-line therapy in a patient with metastatic gastric cancer. Frontiers in Pharmacology. 13. 888106–888106. 1 indexed citations
9.
Chen, Yue, Haoyue Hu, Xue Fan, et al.. (2022). The role of neutrophil extracellular traps in cancer progression, metastasis and therapy. Experimental Hematology and Oncology. 11(1). 99–99. 51 indexed citations
10.
Zhang, Chen, Haoyue Hu, Xiaoyan Wang, Yajuan Zhu, & Ming Jiang. (2021). WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer. Journal of Cancer. 12(18). 5404–5412. 10 indexed citations
11.
Chen, Jingting, et al.. (2021). Adipose-derived cellular therapies prolong graft survival in an allogenic hind limb transplantation model. Stem Cell Research & Therapy. 12(1). 94–94. 13 indexed citations
12.
Wang, Li, Jun He, Haoyue Hu, et al.. (2020). Lung CSC‐derived exosomal miR‐210‐3p contributes to a pro‐metastatic phenotype in lung cancer by targeting FGFRL1. Journal of Cellular and Molecular Medicine. 24(11). 6324–6339. 76 indexed citations
13.
Zhu, Yajuan, Ye Chen, Haoyue Hu, et al.. (2020). Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer With Liver Metastasis. Frontiers in Oncology. 10. 1681–1681. 9 indexed citations
14.
Hu, Haoyue, et al.. (2020). <p>Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway</p>. Cancer Management and Research. Volume 12. 3579–3587. 15 indexed citations
15.
Guo, Fengzhu, et al.. (2019). Co-existence of well-differentiated fetal adenocarcinoma of the lung with tuberculosis in a young female. Medicine. 98(49). e18282–e18282. 1 indexed citations
16.
He, Jun, Li Wang, Chengda Zhang, et al.. (2019). Interleukin-9 promotes tumorigenesis through augmenting angiogenesis in non-small cell lung cancer. International Immunopharmacology. 75. 105766–105766. 17 indexed citations
17.
Hu, Haoyue. (2012). Protein Ubiquitination and Deubiquitination. 13(5). 1 indexed citations
18.
Wu, Ning, et al.. (2011). Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma. 58(6). 482–490. 100 indexed citations
19.
Hu, Haoyue, et al.. (2009). Association between obesity and injury among Taiwanese adults. International Journal of Obesity. 33(8). 878–884. 22 indexed citations
20.
Du, Hai‐Ning & Haoyue Hu. (2002). Ankyrin Repeat Mediated Protein-protein Interaction. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 29(1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fei Lian Breakdown of academic impact, for papers by Zhuoqing Xu Breakdown of academic impact, for papers by He-Li Gao Breakdown of academic impact, for papers by Yongqian Jia Breakdown of academic impact, for papers by Omar Elaskalani Breakdown of academic impact, for papers by Shrey Modi Breakdown of academic impact, for papers by Stephanie Annett Breakdown of academic impact, for papers by Andrea Pretta Breakdown of academic impact, for papers by Tomoyuki Uchihara
Rankless by CCL
2026